Novel Therapies for Neovascular Retinal Disease - Expert Analysis of New Key Data

In this PER On Air Ophthalmology Times Podcast, a panel of experts takes a closer look at newer-generation anti-VEGF agents for the treatment of nAMD and DME, sharing insights into clinical trial and real-world data, patient education, and other important considerations for treatment. Faculty: Roger A. Goldberg, MD, MBA Vitreoretinal Specialist Bay Area Retina Associates Volunteer Faculty California Pacific Medical Center Walnut Creek, CA David R.P. Almeida, MD, PhD, MBA President and CEO Erie Retina Research Center for Advanced Surgical Exploration Erie, PA Jennifer I. Lim, MD, FARVO Marion H. Schenk Esq. Chair in Ophthalmology for Research of the Aging Eye UIC Distinguished Professor of Ophthalmology Director, Retina Service Vice-Chair, Diversity and Inclusion University of Illinois at Chicago Chicago, IL